146 related articles for article (PubMed ID: 19461082)
21. ASC:SIL ratio following implementation of the 2001 Bethesda System.
Quddus MR; Sung CJ; Eklund CM; Reilly ME; Steinhoff MM
Diagn Cytopathol; 2004 Apr; 30(4):240-2. PubMed ID: 15048957
[TBL] [Abstract][Full Text] [Related]
22. Improvement in the routine screening performance of cytotechnologists over time: a study using rapid prescreening.
Brimo F; Renshaw AA; Deschenes M; Charbonneau M; Auger M
Cancer; 2009 Oct; 117(5):311-7. PubMed ID: 19711473
[TBL] [Abstract][Full Text] [Related]
23. [Personnel training for a population screening program for cervical carcinoma].
Branca M; Rossi E; Cedri C; Migliore G; Cedri S; Aldovini A; Leoncini L; Bonelli L; Montanari G; Navone R
Pathologica; 2001 Jun; 93(3):233-41. PubMed ID: 11433619
[No Abstract] [Full Text] [Related]
24. [HPV test for quality control of gynecologic cytological tests].
Wilander E; Wikström I
Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3560, 3564. PubMed ID: 19133586
[No Abstract] [Full Text] [Related]
25. [The European aptitude test for cervical cytopathology].
Branca M
Pathologica; 2001 Feb; 93(1):28-33. PubMed ID: 11294016
[TBL] [Abstract][Full Text] [Related]
26. Quality control in cervical cancer screening: Brazilian experience.
Collaço LM; de Noronha L; Bleggi-Torres LF; Pinheiro DL
Acta Cytol; 2005; 49(6):694-6. PubMed ID: 16450916
[No Abstract] [Full Text] [Related]
27. Determining the utility and effectiveness of the NeoPath AutoPap 300 QC System used routinely.
Fetterman B; Pawlick G; Koo H; Hartinger J; Gilbert C; Connell S
Acta Cytol; 1999; 43(1):13-22. PubMed ID: 9987444
[TBL] [Abstract][Full Text] [Related]
28. Strategies for reducing Papanicolaou smear screening errors: principles derived from data and experience with quality control.
Krieger PA
Arch Pathol Lab Med; 1997 Mar; 121(3):277-81. PubMed ID: 9111118
[TBL] [Abstract][Full Text] [Related]
29. Automated screening versus manual screening: a comparison of the ThinPrep imaging system and manual screening in a time study.
Schledermann D; Hyldebrandt T; Ejersbo D; Hoelund B
Diagn Cytopathol; 2007 Jun; 35(6):348-52. PubMed ID: 17497655
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of 100% rapid rescreening of cervical smears.
Sood N; Singh V
Indian J Pathol Microbiol; 2009; 52(4):495-7. PubMed ID: 19805954
[TBL] [Abstract][Full Text] [Related]
31. Internal quality assurance of sensitivity of primary screening.
Boxer ME
Cytopathology; 1998 Oct; 9(5):349-50. PubMed ID: 9800134
[No Abstract] [Full Text] [Related]
32. [Diagnostic importance of ProEx C in gynecologic cytopathology].
Tambouret RH
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S92-3. PubMed ID: 18984316
[No Abstract] [Full Text] [Related]
33. Report of working party on internal quality control for cervical cytopathology laboratories summary and recommendations.
Cytopathology; 1996 Feb; 7(1):4-9. PubMed ID: 8833868
[No Abstract] [Full Text] [Related]
34. [Quality assurance in anatomo-cytopathology. Cancer of the cervix. Report of a study group].
Bergeron C; Cartier I; Cochand-Priollet B; Daste G; Muller B; Rey C; Sastre-Garau X; Marsan C
Arch Anat Cytol Pathol; 1995; 43(3):154-6. PubMed ID: 7574914
[No Abstract] [Full Text] [Related]
35. Surrogate indicators of sensitivity in gynecologic cytology: can they be used to improve the measurement of sensitivity in the laboratory?
Renshaw AA; Brimo F; Auger M
Cytojournal; 2009 Oct; 6():19. PubMed ID: 19876383
[TBL] [Abstract][Full Text] [Related]
36. Critical values in anatomic pathology: how do we communicate?
LiVolsi VA
Am J Clin Pathol; 2004 Aug; 122(2):171-2. PubMed ID: 15323131
[No Abstract] [Full Text] [Related]
37. Evaluation of the AutoCyte SCREEN system in a clinical cytopathology laboratory.
Bishop JW; Cheuvront DA; Sims KL
Acta Cytol; 2000; 44(2):128-36. PubMed ID: 10740595
[TBL] [Abstract][Full Text] [Related]
38. Rapid pre-screening of Pap smears in quality control: an Italian experience.
Placidi A; Manca G; Mania E; Arbyn M
Cytopathology; 2004 Apr; 15(2):121-3. PubMed ID: 15056176
[No Abstract] [Full Text] [Related]
39. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
Renshaw A
Cancer; 2006 Aug; 108(4):267; author reply 268. PubMed ID: 16671112
[No Abstract] [Full Text] [Related]
40. Lack of generalizability of sensitivity and specificity with treatment effects.
Dodd LE; Korn EL
Stat Med; 2008 May; 27(10):1734-44. PubMed ID: 17940996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
